|Is AIDS Inc Failing Us?
Oct 3, 2012
Given that the paper by Dr. Gero Hütter, detailing a cure of Timothy Ray Brown's HIV infection, was originally rejected by an AIDS Inc employee:
...what hope can we have that the two groups of patients cured of their HIV infections by two Japanese teams (the first group of 15 patients were cured nearly 12 years ago) will ever be followed-up by AIDS Inc?
Here's a copy of an abstract from a 2009 FOCIS meeting on the 2nd group:
Note that the first group was cured with funding from the United Stated Public Health Service (grant# AI-32140)
By my estimates AZT brought in somewhere between $20 Billion and $40 Billion in profits for the four companies that owned (and continue to own) the patent. And it was a very toxic and not very good at suppressing HIV. I hear that Atripla, which has cornered the HIV/AIDS drug market is pulling somewhere between $2 Billion and $3 Billion per year in profits.
With all this profiteering on HIV, it appears that AIDS Inc has no interest in bringing a known cure to patients that would compete with (and perhaps eliminate) their incomes.
What do you think?
| Response from Mr. Chambers
That question should be put to one of the medically trained people on this panel.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.